Trial site
Center For Dermatology Clinical Research, Inc.
- 12running trials
- 13closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)10 trials
- Vitiligo6 trials
- Alopecia areata4 trials
- Psoriasis4 trials
- Hidradenitis suppurativa1 trial
- Obesity1 trial
- Phase
- Phase 311 trials
- Phase 29 trials
- Phase 12 trials
- Phase 42 trials
- Status
- Completed12 trials
- Recruiting8 trials
- Active, not recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Amgen2 trials
- Bristol-Myers Squibb2 trials
- Incyte Corporation2 trials
- Acrotech Biopharma Inc.1 trial
- and 11 more
Running trials
Recruiting
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo
Recruiting
Active, not recruiting
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Psoriasis3 recruiting
- Alopecia areata2 recruiting
- Vitiligo2 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis
Completed
Terminated
Completed
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Completed
Completed
Completed
A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Site data: ClinicalTrials.govUpdated 13 Nov 2026